Branchburg, NJ, United States of America

Ying Ye

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Martinsville, NJ (US) (2016 - 2019)
  • Branchburg, NJ (US) (2019 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Ying Ye

Introduction

Ying Ye is a prominent inventor based in Branchburg, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of systemic lupus erythematosus and other immune-related diseases. With a total of 7 patents to his name, his work continues to impact the medical community.

Latest Patents

Ying Ye's latest patents include a compound for the treatment of systemic lupus erythematosus, which provides methods for using compounds and compositions to treat, manage, and prevent this condition. Additionally, he has developed methods for modulating leukocytic activity in immune-related and inflammatory diseases, offering pharmaceutical compositions and dosing regimens for effective treatment.

Career Highlights

Throughout his career, Ying Ye has worked with notable companies such as Celgene Corporation and Signal Pharmaceuticals, Inc. His expertise in pharmaceutical development has led to advancements in treatments for various diseases, showcasing his dedication to improving patient outcomes.

Collaborations

Ying Ye has collaborated with esteemed colleagues, including Peter Henry Schafer and Lei Wu. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Ying Ye's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…